| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SH3 domain binding | 1.17e-06 | 143 | 109 | 8 | GO:0017124 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | FOXD2 TCF7L2 CEBPA ERF ARX PDX1 ETV3 TEAD4 HMX2 GFI1 LHX1 ZSCAN5B GLI2 RBPJ MKX ZFHX2 DMRTC2 DMRTA2 EPAS1 FOXD1 NPAS1 | 2.21e-05 | 1412 | 109 | 21 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | FOXD2 TCF7L2 CEBPA ARX PDX1 ETV3 TEAD4 HMX2 KDM6B GFI1 LHX1 ZSCAN5B GLI2 RBPJ MKX ZFHX2 DMRTC2 DMRTA2 EPAS1 FOXD1 NPAS1 | 3.59e-05 | 1459 | 109 | 21 | GO:0000977 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | FOXD2 TCF7L2 CEBPA ARX PDX1 TEAD4 KDM6B GFI1 LHX1 ZSCAN5B GLI2 RBPJ MKX ZFHX2 DMRTC2 DMRTA2 EPAS1 FOXD1 | 1.72e-04 | 1271 | 109 | 18 | GO:0000987 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | SHANK1 BCL9L ZSWIM8 ATN1 CBFA2T3 ARID1A GFI1 SH2B1 KMT2C NCOR2 SLC9A1 ABI2 SYN1 RERE ZNF598 QKI ZNF541 | 1.78e-04 | 1160 | 109 | 17 | GO:0030674 |
| GeneOntologyMolecularFunction | chromatin binding | TCF7L2 CEBPA ARX PDX1 KDM6B CBFA2T3 ARID1A NCOR2 TNRC18 GLI2 MCM9 RBPJ RERE | 1.95e-04 | 739 | 109 | 13 | GO:0003682 |
| GeneOntologyMolecularFunction | molecular adaptor activity | SHANK1 COL4A4 BCL9L ZSWIM8 ATN1 CBFA2T3 ARID1A GFI1 SH2B1 KMT2C NCOR2 SLC9A1 ABI2 SYN1 RERE ZNF598 QKI ZNF541 | 3.79e-04 | 1356 | 109 | 18 | GO:0060090 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | FOXD2 TCF7L2 CEBPA ARX PDX1 TEAD4 KDM6B GFI1 ZSCAN5B GLI2 RBPJ MKX ZFHX2 DMRTC2 DMRTA2 EPAS1 FOXD1 | 4.03e-04 | 1244 | 109 | 17 | GO:0000978 |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 8.09e-04 | 8 | 109 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | protein domain specific binding | PLSCR4 SHANK1 TCF7L2 CEBPA ATN1 EFS CNTNAP1 ARHGAP17 DENND1A ABI2 NPTXR SRRM2 QKI | 9.63e-04 | 875 | 109 | 13 | GO:0019904 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 9.86e-04 | 560 | 109 | 10 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.07e-03 | 566 | 109 | 10 | GO:0001216 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.29e-03 | 10 | 109 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | GAPVD1 GARNL3 ARHGAP17 ARHGEF18 GMIP DENND1A TBC1D4 FGD1 SOS2 | 1.84e-03 | 507 | 109 | 9 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | GAPVD1 GARNL3 ARHGAP17 ARHGEF18 GMIP DENND1A TBC1D4 FGD1 SOS2 | 1.84e-03 | 507 | 109 | 9 | GO:0030695 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.05e-03 | 417 | 109 | 8 | GO:0061629 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | TCF7L2 CEBPA ERF ATN1 ARX PDX1 ETV3 CBFA2T3 ARID1A KANK2 GFI1 LHX1 NCOR2 ZNF469 GLI2 RBPJ MKX RERE EPAS1 ZNF541 FOXD1 NPAS1 | 2.42e-06 | 1399 | 107 | 22 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | TCF7L2 CEBPA ERF ATN1 ARX PDX1 ETV3 CBFA2T3 ARID1A KANK2 GFI1 LHX1 NCOR2 ZNF469 GLI2 RBPJ MKX RERE EPAS1 ZNF541 FOXD1 NPAS1 | 2.85e-06 | 1413 | 107 | 22 | GO:1902679 |
| GeneOntologyBiologicalProcess | embryonic organ development | TCF7L2 CEBPA ERF TEAD4 HMX2 ARID1A GFI1 LHX1 GLI2 RBPJ STRC EPAS1 STRCP1 | 6.80e-06 | 561 | 107 | 13 | GO:0048568 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | TCF7L2 CEBPA ERF ATN1 ARX PDX1 ETV3 CBFA2T3 ARID1A KANK2 GFI1 NCOR2 ZNF469 GLI2 RBPJ MKX EPAS1 NPAS1 | 7.48e-06 | 1053 | 107 | 18 | GO:0000122 |
| GeneOntologyBiologicalProcess | cell fate commitment | 1.05e-05 | 338 | 107 | 10 | GO:0045165 | |
| GeneOntologyBiologicalProcess | embryo development | TCF7L2 CEBPA ERF HCN4 MATR3 PDX1 TEAD4 HMX2 KDM6B ARID1A GFI1 LHX1 NCOR2 PHLDB1 SLC9A1 GLI2 RBPJ STRC EPAS1 STRCP1 | 4.40e-05 | 1437 | 107 | 20 | GO:0009790 |
| GeneOntologyBiologicalProcess | myoblast differentiation | 7.70e-05 | 136 | 107 | 6 | GO:0045445 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | TCF7L2 ERF PDX1 HMX2 KDM6B ARID1A GFI1 LHX1 PHLDB1 GLI2 RBPJ STRC STRCP1 | 8.23e-05 | 713 | 107 | 13 | GO:0048598 |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 8.95e-05 | 351 | 107 | 9 | GO:0048562 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | AMPD2 CEBPA ARX PDX1 KDM6B GFI1 LHX1 NCOR2 ABI2 GLI2 RBPJ STRC EPAS1 STRCP1 | 1.62e-04 | 870 | 107 | 14 | GO:0030855 |
| GeneOntologyCellularComponent | chromatin | FOXD2 TCF7L2 CEBPA ERF ARX PDX1 ETV3 TEAD4 HMX2 ARID1A FAAP100 LHX1 NCOR2 RBPJ MKX ZFHX2 DMRTC2 DMRTA2 TAF4 EPAS1 FOXD1 NPAS1 | 6.67e-06 | 1480 | 109 | 22 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | BCL9L TCF7L2 CEBPA ETV3 TEAD4 GFI1 LHX1 NCOR2 RBPJ MKX TAF4 EPAS1 ZNF541 | 1.38e-05 | 596 | 109 | 13 | GO:0005667 |
| MousePheno | perinatal lethality, complete penetrance | ZSWIM8 PSMF1 TCF7L2 CEBPA KMT2B MATR3 ARX KDM6B ARID1A LHX1 KMT2C GLI2 RERE QKI EPAS1 FOXD1 | 1.26e-05 | 712 | 91 | 16 | MP:0011089 |
| Domain | Homeodomain-like | 2.10e-05 | 332 | 107 | 10 | IPR009057 | |
| Domain | Atrophin-like | 3.25e-05 | 2 | 107 | 2 | IPR002951 | |
| Domain | Atrophin-1 | 3.25e-05 | 2 | 107 | 2 | PF03154 | |
| Domain | FYrich_C | 3.22e-04 | 5 | 107 | 2 | IPR003889 | |
| Domain | FYrich_N | 3.22e-04 | 5 | 107 | 2 | IPR003888 | |
| Domain | NUT | 3.22e-04 | 5 | 107 | 2 | IPR024310 | |
| Domain | NUT_N | 3.22e-04 | 5 | 107 | 2 | IPR024309 | |
| Domain | FYRC | 3.22e-04 | 5 | 107 | 2 | SM00542 | |
| Domain | FYRN | 3.22e-04 | 5 | 107 | 2 | SM00541 | |
| Domain | TAFH | 3.22e-04 | 5 | 107 | 2 | SM00549 | |
| Domain | NUT | 3.22e-04 | 5 | 107 | 2 | PF12881 | |
| Domain | TAFH | 3.22e-04 | 5 | 107 | 2 | PS51119 | |
| Domain | FYRN | 3.22e-04 | 5 | 107 | 2 | PF05964 | |
| Domain | FYRC | 3.22e-04 | 5 | 107 | 2 | PF05965 | |
| Domain | FYRC | 3.22e-04 | 5 | 107 | 2 | PS51543 | |
| Domain | FYRN | 3.22e-04 | 5 | 107 | 2 | PS51542 | |
| Domain | TAFH | 3.22e-04 | 5 | 107 | 2 | PF07531 | |
| Domain | TAFH_NHR1 | 3.22e-04 | 5 | 107 | 2 | IPR003894 | |
| Domain | SANT_dom | 4.32e-04 | 26 | 107 | 3 | IPR017884 | |
| Domain | SANT | 5.40e-04 | 28 | 107 | 3 | PS51293 | |
| Domain | DM | 6.70e-04 | 7 | 107 | 2 | PF00751 | |
| Domain | DM_2 | 6.70e-04 | 7 | 107 | 2 | PS50809 | |
| Domain | DM | 6.70e-04 | 7 | 107 | 2 | SM00301 | |
| Domain | - | 6.70e-04 | 7 | 107 | 2 | 4.10.1040.10 | |
| Domain | DM_1 | 6.70e-04 | 7 | 107 | 2 | PS40000 | |
| Domain | DM_DNA-bd | 6.70e-04 | 7 | 107 | 2 | IPR001275 | |
| Domain | Homeobox_CS | 7.08e-04 | 186 | 107 | 6 | IPR017970 | |
| Domain | DMRT/dsx/mab-3 | 8.90e-04 | 8 | 107 | 2 | IPR026607 | |
| Domain | Myb_DNA-binding | 1.05e-03 | 35 | 107 | 3 | PF00249 | |
| Domain | - | 1.22e-03 | 283 | 107 | 7 | 1.10.10.60 | |
| Domain | MYB_LIKE | 1.33e-03 | 38 | 107 | 3 | PS50090 | |
| Domain | KH_1 | 1.33e-03 | 38 | 107 | 3 | PF00013 | |
| Domain | - | 1.44e-03 | 39 | 107 | 3 | 3.30.1370.10 | |
| Domain | KH | 1.55e-03 | 40 | 107 | 3 | SM00322 | |
| Domain | KH_dom | 1.55e-03 | 40 | 107 | 3 | IPR004087 | |
| Domain | BAH | 1.73e-03 | 11 | 107 | 2 | SM00439 | |
| Domain | BAH | 1.73e-03 | 11 | 107 | 2 | PF01426 | |
| Domain | BAH | 1.73e-03 | 11 | 107 | 2 | PS51038 | |
| Domain | BAH_dom | 1.73e-03 | 11 | 107 | 2 | IPR001025 | |
| Domain | KH_TYPE_1 | 1.78e-03 | 42 | 107 | 3 | PS50084 | |
| Domain | KH_dom_type_1 | 2.04e-03 | 44 | 107 | 3 | IPR004088 | |
| Domain | Homeobox | 2.29e-03 | 234 | 107 | 6 | PF00046 | |
| Domain | HOMEOBOX_1 | 2.39e-03 | 236 | 107 | 6 | PS00027 | |
| Domain | ELM2 | 2.43e-03 | 13 | 107 | 2 | PF01448 | |
| Domain | ELM2 | 2.43e-03 | 13 | 107 | 2 | PS51156 | |
| Domain | ELM2_dom | 2.43e-03 | 13 | 107 | 2 | IPR000949 | |
| Domain | ELM2 | 2.43e-03 | 13 | 107 | 2 | SM01189 | |
| Domain | HOX | 2.44e-03 | 237 | 107 | 6 | SM00389 | |
| Domain | HOMEOBOX_2 | 2.54e-03 | 239 | 107 | 6 | PS50071 | |
| Domain | Homeobox_dom | 2.54e-03 | 239 | 107 | 6 | IPR001356 | |
| Domain | SANT | 2.95e-03 | 50 | 107 | 3 | SM00717 | |
| Domain | SANT/Myb | 3.30e-03 | 52 | 107 | 3 | IPR001005 | |
| Domain | Post-SET_dom | 3.70e-03 | 16 | 107 | 2 | IPR003616 | |
| Domain | PostSET | 3.70e-03 | 16 | 107 | 2 | SM00508 | |
| Domain | POST_SET | 3.70e-03 | 16 | 107 | 2 | PS50868 | |
| Domain | DH_1 | 5.66e-03 | 63 | 107 | 3 | PS00741 | |
| Domain | EPHD | 6.97e-03 | 22 | 107 | 2 | PS51805 | |
| Domain | RhoGEF | 6.99e-03 | 68 | 107 | 3 | SM00325 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXD2 TCF7L2 ERF ARX PDX1 ETV3 TEAD4 HMX2 ZFP36L2 GLI2 RBPJ MKX ZFHX2 DMRTC2 DMRTA2 RERE EPAS1 ZNF541 NPAS1 | 9.86e-11 | 908 | 112 | 19 | 19274049 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | TCF7L2 ATN1 TSPOAP1 ARHGEF18 LMTK3 SH2B1 NCOR2 ZNF469 TNRC18 GLI2 PIP4P1 IGSF9B SOS2 | 1.48e-09 | 430 | 112 | 13 | 35044719 |
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L TCF7L2 KMT2B ERF ATN1 FBRSL1 ARID1A KMT2C NCOR2 TNRC18 RERE TAF4 | 1.66e-09 | 351 | 112 | 12 | 38297188 |
| Pubmed | BCL9L TCF7L2 KMT2B ERF ATN1 MATR3 FBRSL1 ETV3 ARID1A LHX1 KMT2C NCOR2 GLI2 PIP4P1 RBPJ RPRD2 RERE TAF4 SRRM2 QKI ZNF687 | 5.36e-09 | 1429 | 112 | 21 | 35140242 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | KMT2B MEX3D FBRSL1 ARHGAP17 SFI1 KDM6B ARID1A FAAP100 ZDHHC8 DENND1A FBXO46 KMT2C NCOR2 PHLDB1 TNRC18 ZFP36L2 DISP2 ZNF687 | 1.61e-08 | 1105 | 112 | 18 | 35748872 |
| Pubmed | 2.93e-08 | 28 | 112 | 5 | 32868762 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PSMF1 TCF7L2 FBRSL1 FBXL17 ARHGEF18 ARID1A DENND1A SH2B1 KMT2C NCOR2 PHLDB1 TNRC18 TBC1D4 GLI2 ZFHX2 RPRD2 IGSF9B RERE TAF4 SOS2 | 5.72e-08 | 1489 | 112 | 20 | 28611215 |
| Pubmed | 2.09e-07 | 191 | 112 | 8 | 24146773 | ||
| Pubmed | GAPVD1 KMT2B MATR3 PTPN23 TEAD4 ARID1A ADD3 KMT2C PHF3 RPRD2 TAF4 ZNF598 | 2.24e-07 | 549 | 112 | 12 | 38280479 | |
| Pubmed | 2.30e-07 | 268 | 112 | 9 | 33640491 | ||
| Pubmed | FOXD2 TCF7L2 CEBPA ERF ARID1A LHX1 KMT2C GLI2 MKX ZFHX2 PHIP EPAS1 ZNF687 | 5.03e-07 | 709 | 112 | 13 | 22988430 | |
| Pubmed | Histone deacetylase-associating Atrophin proteins are nuclear receptor corepressors. | 1.13e-06 | 7 | 112 | 3 | 16481466 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | ZSWIM8 GAPVD1 ERF MEX3D FBRSL1 ETV3 GMIP KANK2 DENND1A ADD3 PHLDB1 ZFP36L2 GORASP1 RBPJ RPRD2 | 1.27e-06 | 1038 | 112 | 15 | 26673895 |
| Pubmed | 1.80e-06 | 8 | 112 | 3 | 12558604 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 2.03e-06 | 180 | 112 | 7 | 35198878 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | AMPD2 GAPVD1 MATR3 ARHGAP17 DENND1A PHLDB1 TBC1D4 FAM171A2 ZFP36L2 PHF3 ZNF598 SRRM2 BICC1 | 4.27e-06 | 861 | 112 | 13 | 36931259 |
| Pubmed | 5.54e-06 | 36 | 112 | 4 | 18094027 | ||
| Pubmed | Hnf1b controls pancreas morphogenesis and the generation of Ngn3+ endocrine progenitors. | 5.54e-06 | 36 | 112 | 4 | 25715395 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 5.99e-06 | 398 | 112 | 9 | 35016035 | |
| Pubmed | 7.00e-06 | 12 | 112 | 3 | 22232429 | ||
| Pubmed | 7.00e-06 | 12 | 112 | 3 | 17938243 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 10814707 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 32103422 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 34910522 | ||
| Pubmed | Regulation of histone demethylase KDM6B by hypoxia-inducible factor-2α. | 1.03e-05 | 2 | 112 | 2 | 25520177 | |
| Pubmed | Notch-effector CSL promotes squamous cell carcinoma by repressing histone demethylase KDM6B. | 1.03e-05 | 2 | 112 | 2 | 29757189 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 24947179 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 11687802 | ||
| Pubmed | The RNA-binding protein QKI5 is a direct target of C/EBPα and delays macrophage differentiation. | 1.03e-05 | 2 | 112 | 2 | 22398723 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 26058934 | ||
| Pubmed | QKI-5 regulates the alternative splicing of cytoskeletal gene ADD3 in lung cancer. | 1.03e-05 | 2 | 112 | 2 | 33196842 | |
| Pubmed | OPTHiS Identifies the Molecular Basis of the Direct Interaction between CSL and SMRT Corepressor. | 1.03e-05 | 2 | 112 | 2 | 30157580 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 10913304 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 1.10e-05 | 544 | 112 | 10 | 28473536 | |
| Pubmed | Cilia-dependent GLI processing in neural crest cells is required for tongue development. | 1.15e-05 | 14 | 112 | 3 | 28286175 | |
| Pubmed | TCF7L2 CEBPA ERF ETV3 ARID1A ZSCAN5B ZFP36L2 RBPJ MKX ZNF598 EPAS1 ZNF687 | 1.21e-05 | 808 | 112 | 12 | 20412781 | |
| Pubmed | SHANK1 AMPD2 HCN4 MATR3 CNTNAP1 ARHGEF18 LMTK3 KANK2 NCOR2 FAM171A2 ABI2 SYN1 TAF4 | 1.41e-05 | 963 | 112 | 13 | 28671696 | |
| Pubmed | Conditional ablation of Notch signaling in pancreatic development. | 1.77e-05 | 16 | 112 | 3 | 18635610 | |
| Pubmed | 1.77e-05 | 16 | 112 | 3 | 21856296 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 1.80e-05 | 457 | 112 | 9 | 32344865 | |
| Pubmed | Beta-catenin is essential for pancreatic acinar but not islet development. | 2.14e-05 | 17 | 112 | 3 | 16192304 | |
| Pubmed | 2.14e-05 | 17 | 112 | 3 | 26180087 | ||
| Pubmed | 2.14e-05 | 17 | 112 | 3 | 10476967 | ||
| Pubmed | The contribution of de novo coding mutations to autism spectrum disorder. | 2.56e-05 | 18 | 112 | 3 | 25363768 | |
| Pubmed | 2.56e-05 | 18 | 112 | 3 | 31412250 | ||
| Pubmed | Cochlear outer hair cell horizontal top connectors mediate mature stereocilia bundle mechanics. | 3.08e-05 | 3 | 112 | 2 | 30801007 | |
| Pubmed | ARID1A and CEBPα cooperatively inhibit UCA1 transcription in breast cancer. | 3.08e-05 | 3 | 112 | 2 | 29980791 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 19131340 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 21518914 | ||
| Pubmed | The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidney. | 3.08e-05 | 3 | 112 | 2 | 26542179 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 24226518 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 18974039 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 22456610 | ||
| Pubmed | Urine Fetuin-A is a biomarker of autosomal dominant polycystic kidney disease progression. | 3.08e-05 | 3 | 112 | 2 | 25888842 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 28877478 | ||
| Pubmed | Fetuin-A is a HIF target that safeguards tissue integrity during hypoxic stress. | 3.08e-05 | 3 | 112 | 2 | 33483479 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 27779233 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | SHANK1 GAPVD1 VGLL3 TCF7L2 ATN1 MATR3 CNTNAP1 NCOR2 TBC1D4 PHF3 GLI2 RERE SRRM2 ZNF687 | 3.33e-05 | 1203 | 112 | 14 | 29180619 |
| Pubmed | 3.56e-05 | 20 | 112 | 3 | 19047629 | ||
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 4.14e-05 | 21 | 112 | 3 | 27626377 | |
| Pubmed | Foxd1 is required for terminal differentiation of anterior hypothalamic neuronal subtypes. | 4.14e-05 | 21 | 112 | 3 | 29679559 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 4.38e-05 | 289 | 112 | 7 | 23752268 | |
| Pubmed | βlinc1 encodes a long noncoding RNA that regulates islet β-cell formation and function. | 4.79e-05 | 22 | 112 | 3 | 26944677 | |
| Pubmed | 4.79e-05 | 22 | 112 | 3 | 25587709 | ||
| Pubmed | Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation. | 6.14e-05 | 4 | 112 | 2 | 19221051 | |
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 34645806 | ||
| Pubmed | Stereocilin-deficient mice reveal the origin of cochlear waveform distortions. | 6.14e-05 | 4 | 112 | 2 | 18849963 | |
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 28441528 | ||
| Pubmed | Wnt5a controls Notch1 signaling through CaMKII-mediated degradation of the SMRT corepressor protein. | 6.14e-05 | 4 | 112 | 2 | 22888005 | |
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 10713164 | ||
| Pubmed | VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle. | 6.14e-05 | 4 | 112 | 2 | 31138678 | |
| Pubmed | Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature. | 6.14e-05 | 4 | 112 | 2 | 30586708 | |
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 32593213 | ||
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 6.14e-05 | 4 | 112 | 2 | 23129768 | |
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 25082981 | ||
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 17150957 | ||
| Pubmed | DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys. | 6.14e-05 | 4 | 112 | 2 | 26731474 | |
| Pubmed | 6.26e-05 | 24 | 112 | 3 | 24163148 | ||
| Pubmed | 6.26e-05 | 24 | 112 | 3 | 23852729 | ||
| Pubmed | ZSWIM8 ERF ATN1 FBRSL1 ARID1A KANK2 NCOR2 ZNF469 RERE TAF4 SRRM2 PHIP ZNF687 | 6.43e-05 | 1116 | 112 | 13 | 31753913 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | TCF7L2 CEBPA KMT2B ERF MATR3 ARID1A KMT2C NCOR2 PHF3 RBPJ RPRD2 TAF4 SRRM2 ZNF687 | 7.29e-05 | 1294 | 112 | 14 | 30804502 |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 8.63e-05 | 560 | 112 | 9 | 21653829 | |
| Pubmed | 8.99e-05 | 27 | 112 | 3 | 30063881 | ||
| Pubmed | Role of neuroepithelial Sonic hedgehog in hypothalamic patterning. | 1.00e-04 | 28 | 112 | 3 | 19474326 | |
| Pubmed | 1.00e-04 | 28 | 112 | 3 | 27740873 | ||
| Pubmed | Two conserved domains in PCIF1 mediate interaction with pancreatic transcription factor PDX-1. | 1.02e-04 | 5 | 112 | 2 | 17126328 | |
| Pubmed | Nuclear localization of CBF1 is regulated by interactions with the SMRT corepressor complex. | 1.02e-04 | 5 | 112 | 2 | 11509665 | |
| Pubmed | 1.02e-04 | 5 | 112 | 2 | 9510020 | ||
| Pubmed | 1.02e-04 | 5 | 112 | 2 | 12861022 | ||
| Pubmed | 1.02e-04 | 5 | 112 | 2 | 10640276 | ||
| Pubmed | 1.02e-04 | 5 | 112 | 2 | 11118884 | ||
| Pubmed | 1.02e-04 | 5 | 112 | 2 | 19118645 | ||
| Pubmed | Ataxin-1 and Brother of ataxin-1 are components of the Notch signalling pathway. | 1.02e-04 | 5 | 112 | 2 | 21475249 | |
| Pubmed | 1.02e-04 | 5 | 112 | 2 | 17052462 | ||
| Pubmed | C/EBPalpha and C/EBPbeta are markers of early liver development. | 1.02e-04 | 5 | 112 | 2 | 16892179 | |
| Pubmed | Impaired spleen formation perturbs morphogenesis of the gastric lobe of the pancreas. | 1.02e-04 | 5 | 112 | 2 | 21738788 | |
| Pubmed | 1.02e-04 | 5 | 112 | 2 | 18039847 | ||
| Pubmed | 1.02e-04 | 5 | 112 | 2 | 24920589 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | GAPVD1 CBFA2T3 KANK2 FAAP100 SH2B1 NCOR2 TBC1D4 ABI2 RBPJ ZNF598 FOXD1 | 1.04e-04 | 857 | 112 | 11 | 25609649 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.07e-04 | 231 | 112 | 6 | 16452087 | |
| Interaction | CRX interactions | VPS37C BCL9L PSMF1 TCF7L2 ERF ATN1 FBRSL1 SFI1 ARID1A KANK2 KMT2C NCOR2 TNRC18 ABI2 RERE | 7.52e-12 | 254 | 109 | 15 | int:CRX |
| Interaction | TLE3 interactions | BCL9L TCF7L2 CEBPA ATN1 FBRSL1 ARID1A NCOR2 TNRC18 TBC1D4 GLI2 RERE TAF4 SRRM2 QKI | 1.57e-08 | 376 | 109 | 14 | int:TLE3 |
| Interaction | EGR2 interactions | 3.81e-07 | 171 | 109 | 9 | int:EGR2 | |
| Interaction | GSC interactions | 4.56e-07 | 87 | 109 | 7 | int:GSC | |
| Interaction | PAX9 interactions | 5.31e-07 | 130 | 109 | 8 | int:PAX9 | |
| Interaction | SP7 interactions | BCL9L TCF7L2 KMT2B ATN1 FBRSL1 ARID1A KMT2C NCOR2 RPRD2 RERE QKI | 7.94e-07 | 304 | 109 | 11 | int:SP7 |
| Interaction | SOX7 interactions | 5.47e-06 | 82 | 109 | 6 | int:SOX7 | |
| Interaction | ZNF34 interactions | 6.66e-06 | 49 | 109 | 5 | int:ZNF34 | |
| Interaction | PHF20 interactions | 9.85e-06 | 53 | 109 | 5 | int:PHF20 | |
| Interaction | FOXI1 interactions | 1.07e-05 | 92 | 109 | 6 | int:FOXI1 | |
| Interaction | LHX1 interactions | 2.04e-05 | 103 | 109 | 6 | int:LHX1 | |
| Interaction | HDAC1 interactions | GAPVD1 TCF7L2 CEBPA KMT2B MATR3 PDX1 CBFA2T3 ARID1A GFI1 NCOR2 TNRC18 TBC1D4 GLI2 RBPJ MKX RERE EPAS1 ZNF687 | 2.63e-05 | 1108 | 109 | 18 | int:HDAC1 |
| Interaction | TLE5 interactions | FOXD2 VPS37C PSMF1 TCF7L2 ERF ATN1 ARX TEAD4 KANK2 ABI2 NPAS1 | 2.84e-05 | 443 | 109 | 11 | int:TLE5 |
| Interaction | ERG interactions | 2.89e-05 | 223 | 109 | 8 | int:ERG | |
| Interaction | GCM1 interactions | 3.35e-05 | 68 | 109 | 5 | int:GCM1 | |
| Interaction | TBR1 interactions | 3.44e-05 | 113 | 109 | 6 | int:TBR1 | |
| Interaction | TOP3B interactions | KMT2B MEX3D FBRSL1 ARHGAP17 SFI1 KDM6B ARID1A KANK2 FAAP100 ZDHHC8 DENND1A FBXO46 KMT2C NCOR2 PHLDB1 TNRC18 ZFP36L2 AHSG DISP2 ZNF598 ZNF687 | 3.50e-05 | 1470 | 109 | 21 | int:TOP3B |
| Interaction | TBXT interactions | 3.99e-05 | 116 | 109 | 6 | int:TBXT | |
| Interaction | KRTAP19-7 interactions | 4.19e-05 | 117 | 109 | 6 | int:KRTAP19-7 | |
| Interaction | PIN1 interactions | 4.38e-05 | 383 | 109 | 10 | int:PIN1 | |
| Interaction | B4GALT2 interactions | 4.61e-05 | 119 | 109 | 6 | int:B4GALT2 | |
| Interaction | TEAD1 interactions | 4.85e-05 | 176 | 109 | 7 | int:TEAD1 | |
| Interaction | NPAS1 interactions | 5.62e-05 | 245 | 109 | 8 | int:NPAS1 | |
| Interaction | ALG13 interactions | 6.20e-05 | 183 | 109 | 7 | int:ALG13 | |
| Interaction | TBL1Y interactions | 6.37e-05 | 40 | 109 | 4 | int:TBL1Y | |
| Interaction | HDAC2 interactions | TCF7L2 CEBPA MATR3 PDX1 CBFA2T3 ARID1A GFI1 NCOR2 RBPJ RPRD2 RERE ZNF598 SRRM2 EPAS1 ZNF687 | 6.44e-05 | 865 | 109 | 15 | int:HDAC2 |
| Interaction | KRTAP6-2 interactions | 7.11e-05 | 187 | 109 | 7 | int:KRTAP6-2 | |
| Interaction | KMT2B interactions | 7.55e-05 | 130 | 109 | 6 | int:KMT2B | |
| Interaction | CBFA2T2 interactions | 1.02e-04 | 45 | 109 | 4 | int:CBFA2T2 | |
| Interaction | KANSL3 interactions | 1.04e-04 | 86 | 109 | 5 | int:KANSL3 | |
| Interaction | FEV interactions | 1.19e-04 | 203 | 109 | 7 | int:FEV | |
| Interaction | PRMT2 interactions | 1.36e-04 | 91 | 109 | 5 | int:PRMT2 | |
| Interaction | NUP43 interactions | BCL9L KMT2B ERF ATN1 ARID1A NCOR2 ZFP36L2 RERE TAF4 SRRM2 PHIP ZNF687 | 1.44e-04 | 625 | 109 | 12 | int:NUP43 |
| Interaction | TCF12 interactions | 1.54e-04 | 148 | 109 | 6 | int:TCF12 | |
| Interaction | RBBP5 interactions | 1.68e-04 | 287 | 109 | 8 | int:RBBP5 | |
| Interaction | DDX20 interactions | 2.18e-04 | 224 | 109 | 7 | int:DDX20 | |
| Interaction | CNTNAP2 interactions | 2.20e-04 | 158 | 109 | 6 | int:CNTNAP2 | |
| Interaction | MED10 interactions | 2.32e-04 | 102 | 109 | 5 | int:MED10 | |
| Interaction | MED27 interactions | 2.32e-04 | 102 | 109 | 5 | int:MED27 | |
| Interaction | NFIX interactions | 2.36e-04 | 227 | 109 | 7 | int:NFIX | |
| Interaction | KRTAP6-1 interactions | 2.43e-04 | 103 | 109 | 5 | int:KRTAP6-1 | |
| Interaction | YAP1 interactions | BCL9L GAPVD1 KMT2B ATN1 MATR3 TEAD4 ARID1A ADD3 KMT2C TNRC18 PHF3 PIP4P1 RPRD2 IGSF9B TAF4 SRRM2 | 2.62e-04 | 1095 | 109 | 16 | int:YAP1 |
| Interaction | NR6A1 interactions | 2.87e-04 | 24 | 109 | 3 | int:NR6A1 | |
| Interaction | LHX4 interactions | 2.87e-04 | 166 | 109 | 6 | int:LHX4 | |
| Interaction | AR interactions | BCL9L TCF7L2 CEBPA ATN1 MATR3 ETV3 ARID1A KMT2C NCOR2 TNRC18 PHF3 GLI2 RBPJ RPRD2 RERE | 2.89e-04 | 992 | 109 | 15 | int:AR |
| Interaction | SULT1C4 interactions | 3.29e-04 | 110 | 109 | 5 | int:SULT1C4 | |
| Interaction | GATA1 interactions | 3.36e-04 | 171 | 109 | 6 | int:GATA1 | |
| Interaction | HSPB8 interactions | 3.47e-04 | 172 | 109 | 6 | int:HSPB8 | |
| Interaction | P4HA3 interactions | 3.73e-04 | 113 | 109 | 5 | int:P4HA3 | |
| Interaction | TLX1 interactions | 3.81e-04 | 175 | 109 | 6 | int:TLX1 | |
| Interaction | DTX2 interactions | 4.30e-04 | 330 | 109 | 8 | int:DTX2 | |
| Interaction | PPARD interactions | 4.37e-04 | 117 | 109 | 5 | int:PPARD | |
| Interaction | SSBP3 interactions | 4.73e-04 | 119 | 109 | 5 | int:SSBP3 | |
| Interaction | NUP35 interactions | 4.95e-04 | 424 | 109 | 9 | int:NUP35 | |
| Interaction | RAPGEFL1 interactions | 5.08e-04 | 29 | 109 | 3 | int:RAPGEFL1 | |
| Interaction | LHX3 interactions | 5.11e-04 | 185 | 109 | 6 | int:LHX3 | |
| Interaction | RBPMS interactions | 5.24e-04 | 340 | 109 | 8 | int:RBPMS | |
| Interaction | ETV4 interactions | 5.34e-04 | 69 | 109 | 4 | int:ETV4 | |
| Interaction | GATA3 interactions | 5.41e-04 | 187 | 109 | 6 | int:GATA3 | |
| Cytoband | 9q33.3 | 1.03e-04 | 37 | 112 | 3 | 9q33.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | SHANK1 CEBPA KMT2B ERF LMTK3 FBXO46 ZSCAN5B DMRTC2 ZNF541 NPAS1 | 6.95e-04 | 1192 | 112 | 10 | chr19q13 |
| Cytoband | 16q24 | 7.83e-04 | 17 | 112 | 2 | 16q24 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | AMPD2 ATN1 FBRSL1 ARHGAP17 TEAD4 FBXO46 NUTM2E ZNF598 SRRM2 CAPN15 | 1.97e-06 | 338 | 112 | 10 | M17094 |
| Coexpression | BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN | 1.19e-05 | 118 | 112 | 6 | M34005 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN | 2.50e-05 | 200 | 112 | 7 | M5851 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-07 | 199 | 112 | 7 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-07 | 199 | 112 | 7 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-06 | 159 | 112 | 6 | 656aa20706bdba81bbcc3e68e6058215b92b8802 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.99e-06 | 166 | 112 | 6 | c8a7d94ed762e5e045ab5f74eef691ddc5f74993 | |
| ToppCell | droplet-Fat-Bat-18m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-06 | 170 | 112 | 6 | c720d81bc29a8fd1f1249c6af408471d561f1d5d | |
| ToppCell | droplet-Fat-Bat|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-06 | 170 | 112 | 6 | c4ecdfc2b4710da0a5fbb20e9df02536023badb1 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 5.40e-06 | 175 | 112 | 6 | f6a6db992e803d36c866a91706b02f67e0fd3e09 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-06 | 186 | 112 | 6 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.91e-06 | 191 | 112 | 6 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 9.18e-06 | 192 | 112 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 9.74e-06 | 194 | 112 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.00e-05 | 195 | 112 | 6 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.00e-05 | 195 | 112 | 6 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.06e-05 | 197 | 112 | 6 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.18e-05 | 133 | 112 | 5 | 63d2f096ae47d9b587acc6c5fbd346e5e58842b8 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.69e-05 | 139 | 112 | 5 | a957ea4e581646c76b16b6a7f89579b8c7ac35b6 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Sncg_(Neuron.Gad1Gad2.Synpr-Sncg)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.78e-05 | 69 | 112 | 4 | 9778ec48eceef5bd6f59b5b55ca4a6cc348a1eba | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Sncg_(Neuron.Gad1Gad2.Synpr-Sncg)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.78e-05 | 69 | 112 | 4 | 8c4c4e2cd4c319adbe44fa2bcb5bb5cd5d81a2fd | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.29e-05 | 72 | 112 | 4 | 7877184d5c9dd6d96476d71e7504e58c0b4d0f26 | |
| ToppCell | E16.5-samps-Mesenchymal-Pericyte|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.64e-05 | 148 | 112 | 5 | e697a7fb037873c9b11703d1bf836a69fc276e23 | |
| ToppCell | E16.5-samps-Mesenchymal-Pericyte-pericyte_A|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.64e-05 | 148 | 112 | 5 | c87fe2373418ec0cfe37279003d1c4df4c0d0aac | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.28e-05 | 166 | 112 | 5 | a7ac5a414e3e2ff01f1c452c0a85048b17cba0b6 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 169 | 112 | 5 | 573f85075d83a4baba41c3e24dc4d9831823a5e5 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.83e-05 | 169 | 112 | 5 | b2d53159e344fad6fcdc485d5b8f6cf1bf094b1f | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 6.83e-05 | 169 | 112 | 5 | 625788d86f0ceebcf2653a251db1f1a9f9746d29 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 169 | 112 | 5 | a24d12199b1a6d9cb243b3a68f4109d3a30b2dcb | |
| ToppCell | Posterior_cortex-Macroglia|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.06e-05 | 175 | 112 | 5 | 8bc7a3856d04692989b2a1675ea6d9392261d55a | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-05 | 176 | 112 | 5 | 24b2e94ee5defcefb64a1f2447a2cc71b015b0fd | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.73e-05 | 178 | 112 | 5 | cc0382b0ee1e6c76522e2c86ad1425c45debab5d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.96e-05 | 179 | 112 | 5 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 180 | 112 | 5 | 41e8155cc7b3dac9d496e4077845ca6af1591a5c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.44e-05 | 181 | 112 | 5 | 634a4f4e5942473e60d08d0b0936407b04bc6b7c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte-Peri_L1-6_MUSTN1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.44e-05 | 181 | 112 | 5 | c2938cf1f5d4875be07a56a1f36c94f8eab37d99 | |
| ToppCell | facs-Heart-LV-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-05 | 182 | 112 | 5 | 6dff753d65ba45db81f3cc0c9f59e1779d490955 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.69e-05 | 182 | 112 | 5 | 9d727ab84da8de33f1021b492c90d8b4c2a8ea23 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.94e-05 | 183 | 112 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 185 | 112 | 5 | 3f1aa91efae2d00320d126087cce1431ad5f26ea | |
| ToppCell | Cerebellum-Neuronal|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.10e-04 | 187 | 112 | 5 | 61b9d6eb131a674598aa8409d7fa909c8765442d | |
| ToppCell | PBMC-Mild-cDC_5|Mild / Compartment, Disease Groups and Clusters | 1.10e-04 | 187 | 112 | 5 | 0afef5baf3752314dbfb024790347d5e51f9b84b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 188 | 112 | 5 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 189 | 112 | 5 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | facs-Pancreas-Endocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 189 | 112 | 5 | 010fdd70e9d0e21b856306a29ff877776a480319 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-04 | 191 | 112 | 5 | 24dc77ee8de01b42559f92721655f4281b114e17 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 191 | 112 | 5 | 2f733d510a4862565a817f59829d8387d7ea26d9 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 191 | 112 | 5 | a251b134f67a0a1ef3a42f50042f128a17f20b22 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-04 | 193 | 112 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.28e-04 | 193 | 112 | 5 | 9d0b966d13cbce97beb43de6dc77f006c363a181 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.28e-04 | 193 | 112 | 5 | 64edc1d6fb0fe117767d494cf4a5723bf8be2804 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 194 | 112 | 5 | 0797245ebfa389a6f66874cb0f11297f1456e600 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.31e-04 | 194 | 112 | 5 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 194 | 112 | 5 | 0241b4b88d6210b4c1b8aa99db17115b18142f01 | |
| ToppCell | Mild/Remission-B_memory-0|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.31e-04 | 194 | 112 | 5 | 4866093b50cdf895f06b60684cc3aaa9769aa4dc | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-neutrophil-promyelocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.37e-04 | 196 | 112 | 5 | 8ff0135e108764a3527acc00a994ced342e1cad1 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.37e-04 | 196 | 112 | 5 | 7be50b9156394dea44d7b8b476d4dd516abfafae | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 197 | 112 | 5 | 173c0c8de4e69882a9f91189deeb4a651fefe551 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 1.44e-04 | 198 | 112 | 5 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-04 | 199 | 112 | 5 | 5b6feacb0ca92c3fc6b327be978320426dcf6f68 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.47e-04 | 199 | 112 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-04 | 199 | 112 | 5 | a13f4b8a039304e685464cc8879659824cad5a3e | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.47e-04 | 199 | 112 | 5 | fcbb3a9c0f4c5b4c1f09db24b9f50cc1166fa43b | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.51e-04 | 200 | 112 | 5 | 2022df85df94ab8cbb4e80e3fe9894c01051c5e0 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.51e-04 | 200 | 112 | 5 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | normal_Lung-Fibroblasts-COL14A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.51e-04 | 200 | 112 | 5 | 6d8f6a6b3f61c529fbed1376659641030abf4f2c | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.51e-04 | 200 | 112 | 5 | 69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.51e-04 | 200 | 112 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| Drug | Parbendazole [14255-87-9]; Down 200; 16.2uM; PC3; HT_HG-U133A | 3.85e-07 | 193 | 109 | 9 | 3799_DN | |
| Drug | Nifedipine [21829-25-4]; Up 200; 11.6uM; PC3; HT_HG-U133A | 4.02e-07 | 194 | 109 | 9 | 1814_UP | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; PC3; HT_HG-U133A | 4.02e-07 | 194 | 109 | 9 | 1217_DN | |
| Drug | Sertaconazole nitrate [99592-39-9]; Up 200; 8uM; PC3; HT_HG-U133A | 4.58e-07 | 197 | 109 | 9 | 4475_UP | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 4.98e-07 | 199 | 109 | 9 | 3430_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.31e-06 | 178 | 109 | 8 | 4710_DN | |
| Drug | Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A | 4.38e-06 | 194 | 109 | 8 | 5384_DN | |
| Drug | Lymecycline [992-21-2]; Down 200; 6.6uM; HL60; HT_HG-U133A | 4.73e-06 | 196 | 109 | 8 | 2953_DN | |
| Drug | Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 5.09e-06 | 198 | 109 | 8 | 3738_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.25e-05 | 176 | 109 | 7 | 2639_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.25e-05 | 176 | 109 | 7 | 5976_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.33e-05 | 177 | 109 | 7 | 7550_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.33e-05 | 177 | 109 | 7 | 6551_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.42e-05 | 178 | 109 | 7 | 6276_DN | |
| Drug | Desipramine hydrochloride [58-28-6]; Up 200; 13.2uM; PC3; HT_HG-U133A | 3.79e-05 | 191 | 109 | 7 | 6693_UP | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 4.05e-05 | 193 | 109 | 7 | 3262_UP | |
| Drug | 5155877; Down 200; 10uM; MCF7; HT_HG-U133A | 4.05e-05 | 193 | 109 | 7 | 6574_DN | |
| Drug | Cyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A | 4.19e-05 | 194 | 109 | 7 | 4411_DN | |
| Drug | Pentolinium bitartrate [52-62-0]; Up 200; 7.4uM; PC3; HT_HG-U133A | 4.19e-05 | 194 | 109 | 7 | 3676_UP | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A | 4.19e-05 | 194 | 109 | 7 | 4242_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; PC3; HT_HG-U133A | 4.33e-05 | 195 | 109 | 7 | 1214_UP | |
| Drug | Cholecalciferol [67-97-0]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 4.33e-05 | 195 | 109 | 7 | 3298_UP | |
| Drug | Naringenine [480-41-1]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 4.33e-05 | 195 | 109 | 7 | 3278_UP | |
| Drug | prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | 4.33e-05 | 195 | 109 | 7 | 6552_DN | |
| Drug | Iocetamic acid [16034-77-8]; Up 200; 6.6uM; PC3; HT_HG-U133A | 4.47e-05 | 196 | 109 | 7 | 4600_UP | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 4.47e-05 | 196 | 109 | 7 | 2314_DN | |
| Drug | Morantel tartrate [26155-31-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 4.62e-05 | 197 | 109 | 7 | 1676_UP | |
| Drug | Roxithromycin [80214-83-1]; Up 200; 4.8uM; PC3; HT_HG-U133A | 4.62e-05 | 197 | 109 | 7 | 4192_UP | |
| Drug | Primidone [125-33-7]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 4.77e-05 | 198 | 109 | 7 | 3402_DN | |
| Drug | Cisapride [81098-60-4]; Up 200; 8.6uM; PC3; HT_HG-U133A | 4.77e-05 | 198 | 109 | 7 | 6706_UP | |
| Drug | Tolmetin sodium salt dihydrate [64490-92-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 4.77e-05 | 198 | 109 | 7 | 3347_DN | |
| Drug | Reserpine [50-55-5]; Down 200; 6.6uM; PC3; HT_HG-U133A | 4.77e-05 | 198 | 109 | 7 | 4203_DN | |
| Drug | Methazolamide [554-57-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 4.92e-05 | 199 | 109 | 7 | 6268_DN | |
| Drug | Zidovudine, AZT [30516-87-1]; Up 200; 15uM; MCF7; HT_HG-U133A | 4.92e-05 | 199 | 109 | 7 | 5333_UP | |
| Drug | Tyloxapol [25301-02-4]; Up 200; 4uM; MCF7; HT_HG-U133A | 4.92e-05 | 199 | 109 | 7 | 6452_UP | |
| Drug | 2-Chloropyrazine [14508-49-7]; Up 200; 35uM; MCF7; HT_HG-U133A | 4.92e-05 | 199 | 109 | 7 | 3570_UP | |
| Drug | 5707885; Down 200; 50uM; MCF7; HT_HG-U133A | 4.92e-05 | 199 | 109 | 7 | 6433_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; PC3; HT_HG-U133A | 5.08e-05 | 200 | 109 | 7 | 3779_UP | |
| Drug | NSC626122 | 6.79e-05 | 3 | 109 | 2 | CID000362378 | |
| Drug | AC1L9IIO | 6.79e-05 | 3 | 109 | 2 | CID000445749 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.35e-04 | 163 | 109 | 6 | 7453_DN | |
| Drug | N-(2-hydroxyethyl)phenazinium | 1.35e-04 | 4 | 109 | 2 | CID000125436 | |
| Drug | 6-amino-2-mercaptopyrimidin-4-ol | 1.35e-04 | 4 | 109 | 2 | CID001201441 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.40e-04 | 164 | 109 | 6 | 4388_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 1.54e-04 | 167 | 109 | 6 | 5217_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.60e-04 | 168 | 109 | 6 | 3868_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.70e-04 | 170 | 109 | 6 | 1050_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.81e-04 | 172 | 109 | 6 | 1072_DN | |
| Drug | troglitazone; Up 200; 10uM; PC3; HT_HG-U133A | 1.87e-04 | 173 | 109 | 6 | 1232_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.93e-04 | 174 | 109 | 6 | 1659_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.99e-04 | 175 | 109 | 6 | 6891_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.18e-04 | 178 | 109 | 6 | 1112_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.18e-04 | 178 | 109 | 6 | 992_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A | 2.25e-04 | 179 | 109 | 6 | 1175_DN | |
| Drug | trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A | 2.25e-04 | 179 | 109 | 6 | 331_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A | 2.77e-04 | 186 | 109 | 6 | 2694_DN | |
| Drug | Colchicine [64-86-8]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.01e-04 | 189 | 109 | 6 | 5675_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 10000uM; HL60; HG-U133A | 3.01e-04 | 189 | 109 | 6 | 410_DN | |
| Drug | Clioquinol [130-26-7]; Up 200; 13uM; PC3; HT_HG-U133A | 3.10e-04 | 190 | 109 | 6 | 4663_UP | |
| Drug | thapsigargin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.19e-04 | 191 | 109 | 6 | 7100_DN | |
| Drug | retinoic acid; Up 200; 1uM; PC3; HT_HG-U133A | 3.19e-04 | 191 | 109 | 6 | 1211_UP | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Up 200; 22.2uM; MCF7; HT_HG-U133A | 3.28e-04 | 192 | 109 | 6 | 2831_UP | |
| Drug | Pipemidic acid [51940-44-4]; Down 200; 13.2uM; PC3; HT_HG-U133A | 3.28e-04 | 192 | 109 | 6 | 6752_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 3.28e-04 | 192 | 109 | 6 | 5222_DN | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 3.28e-04 | 192 | 109 | 6 | 6054_DN | |
| Drug | ATN-2 | 3.36e-04 | 6 | 109 | 2 | CID003081684 | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 3.37e-04 | 193 | 109 | 6 | 5584_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.37e-04 | 193 | 109 | 6 | 6967_DN | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; PC3; HT_HG-U133A | 3.37e-04 | 193 | 109 | 6 | 4202_DN | |
| Drug | Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 3.37e-04 | 193 | 109 | 6 | 4725_UP | |
| Drug | indomethacin, USP; Up 200; 20uM; MCF7; HG-U133A | 3.37e-04 | 193 | 109 | 6 | 262_UP | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; HL60; HG-U133A | 3.37e-04 | 193 | 109 | 6 | 1982_DN | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.37e-04 | 193 | 109 | 6 | 7232_DN | |
| Drug | Nilutamide [63612-50-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 3.47e-04 | 194 | 109 | 6 | 5362_UP | |
| Drug | Trazodone hydrochloride [25332-39-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 3.47e-04 | 194 | 109 | 6 | 7410_UP | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.47e-04 | 194 | 109 | 6 | 4763_DN | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A | 3.47e-04 | 194 | 109 | 6 | 4284_DN | |
| Drug | Norethindrone [68-22-4]; Up 200; 13.4uM; PC3; HT_HG-U133A | 3.47e-04 | 194 | 109 | 6 | 5055_UP | |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 3.47e-04 | 194 | 109 | 6 | 1699_DN | |
| Drug | Nadolol [42200-33-9]; Up 200; 13uM; MCF7; HT_HG-U133A | 3.47e-04 | 194 | 109 | 6 | 4139_UP | |
| Drug | semustine; Up 200; 100uM; PC3; HT_HG-U133A | 3.47e-04 | 194 | 109 | 6 | 7492_UP | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; MCF7; HT_HG-U133A | 3.47e-04 | 194 | 109 | 6 | 3384_DN | |
| Drug | Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; HL60; HT_HG-U133A | 3.47e-04 | 194 | 109 | 6 | 3035_DN | |
| Drug | 0316684-0000 [391209-55-5]; Down 200; 10uM; PC3; HT_HG-U133A | 3.47e-04 | 194 | 109 | 6 | 7098_DN | |
| Drug | Sulfanilamide [63-74-1]; Up 200; 23.2uM; PC3; HT_HG-U133A | 3.47e-04 | 194 | 109 | 6 | 4474_UP | |
| Drug | radicicol; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.47e-04 | 194 | 109 | 6 | 5952_DN | |
| Drug | Mebendazole [31431-39-7]; Down 200; 13.6uM; PC3; HT_HG-U133A | 3.47e-04 | 194 | 109 | 6 | 3671_DN | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.56e-04 | 195 | 109 | 6 | 6059_DN | |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; PC3; HG-U133A | 3.56e-04 | 195 | 109 | 6 | 1884_UP | |
| Drug | Hecogenin [467-55-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 3.56e-04 | 195 | 109 | 6 | 7175_UP | |
| Drug | Hydroflumethiazide [135-09-1]; Down 200; 12uM; MCF7; HT_HG-U133A | 3.56e-04 | 195 | 109 | 6 | 1687_DN | |
| Drug | Adiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; PC3; HT_HG-U133A | 3.56e-04 | 195 | 109 | 6 | 1831_UP | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; PC3; HT_HG-U133A | 3.56e-04 | 195 | 109 | 6 | 3984_DN | |
| Drug | Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 3.56e-04 | 195 | 109 | 6 | 4398_DN | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Up 200; 13.6uM; HL60; HT_HG-U133A | 3.66e-04 | 196 | 109 | 6 | 2961_UP | |
| Drug | 5162773; Down 200; 7uM; MCF7; HT_HG-U133A_EA | 3.66e-04 | 196 | 109 | 6 | 892_DN | |
| Drug | Bisoprolol fumarate; Down 200; 9uM; PC3; HT_HG-U133A | 3.66e-04 | 196 | 109 | 6 | 6748_DN | |
| Drug | Retinoic acid [302-79-4]; Up 200; 13.4uM; PC3; HT_HG-U133A | 3.66e-04 | 196 | 109 | 6 | 5767_UP | |
| Drug | clozapine; Up 200; 10uM; MCF7; HT_HG-U133A | 3.66e-04 | 196 | 109 | 6 | 5226_UP | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; PC3; HT_HG-U133A | 3.66e-04 | 196 | 109 | 6 | 7298_DN | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 1.35e-05 | 2 | 109 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | dentatorubral-pallidoluysian atrophy (implicated_via_orthology) | 1.35e-05 | 2 | 109 | 2 | DOID:0060162 (implicated_via_orthology) | |
| Disease | Tourette syndrome, schizophrenia | 3.84e-05 | 18 | 109 | 3 | EFO_0004895, MONDO_0005090 | |
| Disease | Endometrial Stromal Sarcoma | 1.34e-04 | 5 | 109 | 2 | C0206630 | |
| Disease | Klatskin's tumor (is_implicated_in) | 1.34e-04 | 5 | 109 | 2 | DOID:4927 (is_implicated_in) | |
| Disease | Clear cell sarcoma of kidney | 2.01e-04 | 6 | 109 | 2 | C0334488 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 2.21e-04 | 147 | 109 | 5 | DOID:9352 (biomarker_via_orthology) | |
| Disease | worry measurement | 2.74e-04 | 154 | 109 | 5 | EFO_0009589 | |
| Disease | basophil count | 4.36e-04 | 483 | 109 | 8 | EFO_0005090 | |
| Disease | free androgen index | 4.89e-04 | 374 | 109 | 7 | EFO_0007005 | |
| Disease | intraocular pressure measurement | 6.15e-04 | 509 | 109 | 8 | EFO_0004695 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 8.02e-04 | 195 | 109 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | lymphocyte percentage of leukocytes | CEBPA TSPOAP1 ARHGEF18 GMIP CBFA2T3 ARID1A GFI1 ZFP36L2 RERE | 8.19e-04 | 665 | 109 | 9 | EFO_0007993 |
| Disease | testosterone measurement | VGLL3 KDM6B ARID1A GFI1 SH2B1 NCOR2 MCM9 FGD1 DMRTA2 TAF4 PHIP EPAS1 SOS2 | 8.58e-04 | 1275 | 109 | 13 | EFO_0004908 |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 8.99e-04 | 200 | 109 | 5 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | Colorectal Carcinoma | 1.20e-03 | 702 | 109 | 9 | C0009402 | |
| Disease | dystonia (is_implicated_in) | 1.20e-03 | 14 | 109 | 2 | DOID:543 (is_implicated_in) | |
| Disease | total blood protein measurement | 1.42e-03 | 449 | 109 | 7 | EFO_0004536 | |
| Disease | basophil measurement | 1.44e-03 | 60 | 109 | 3 | EFO_0803539 | |
| Disease | sex interaction measurement, ulcerative colitis | 1.77e-03 | 17 | 109 | 2 | EFO_0000729, EFO_0008343 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.77e-03 | 17 | 109 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 1.83e-03 | 346 | 109 | 6 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | obstructive sleep apnea | 1.89e-03 | 66 | 109 | 3 | EFO_0003918 | |
| Disease | neutrophil percentage of leukocytes | 1.95e-03 | 610 | 109 | 8 | EFO_0007990 | |
| Disease | heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease, cancer | 2.46e-03 | 20 | 109 | 2 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004352, MONDO_0004992 | |
| Disease | corneal hysteresis | 2.46e-03 | 20 | 109 | 2 | EFO_0010066 | |
| Disease | Left Ventricle Remodeling | 2.71e-03 | 21 | 109 | 2 | C0600520 | |
| Disease | Ventricular Remodeling | 2.71e-03 | 21 | 109 | 2 | C0600519 | |
| Disease | hyperglycemia (biomarker_via_orthology) | 2.71e-03 | 21 | 109 | 2 | DOID:4195 (biomarker_via_orthology) | |
| Disease | unipolar depression, bipolar disorder | 2.72e-03 | 156 | 109 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | granulocyte percentage of myeloid white cells | 3.23e-03 | 268 | 109 | 5 | EFO_0007997 | |
| Disease | Headache, type 2 diabetes mellitus | 3.25e-03 | 23 | 109 | 2 | HP_0002315, MONDO_0005148 | |
| Disease | Intrahepatic Cholangiocarcinoma | 3.54e-03 | 24 | 109 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 3.54e-03 | 24 | 109 | 2 | C3805278 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HTAGLSFIPGPPGPP | 1206 | Q9UMD9 | |
| GPEPLSPFPVSPLAG | 241 | P50548 | |
| FLGAAPLGPPVSPPH | 661 | Q99814 | |
| PGLPTLLPHPGPFGS | 506 | Q9HCM7 | |
| YLPPTSEGGLPHSPP | 351 | Q8NCV1 | |
| GRHSPAPPPDPGFPA | 1296 | Q6ZSZ5 | |
| YHPGSKPPLPTSGPA | 1326 | P78357 | |
| GPPAPPNPFSHLTEG | 546 | Q9UEY8 | |
| PAHPGSPIDVRVPFP | 56 | P15085 | |
| PDPHSPFAVSPIPGR | 241 | P41162 | |
| PVPHRPPFEPGSAVA | 856 | P54259 | |
| DPASHFGPPGPKGEP | 1076 | P53420 | |
| PFPPSVLSHPSPPEG | 96 | Q8N1L1 | |
| APGTEPHVAPGRAPP | 131 | Q495Z4 | |
| GPDTPVSADAPVHPP | 286 | Q01433 | |
| PTYGHTAPSPPPGLT | 536 | Q9H694 | |
| GLPAPLQAGPAAPPH | 401 | Q96SC8 | |
| TLPPPGGQVFRPSHP | 731 | A7MBM2 | |
| VFPAPAGSAGTPPLP | 281 | Q9NYB9 | |
| GTPHPTAAIVPPGPE | 266 | Q96PU8 | |
| SPGPGDPSSPLQHPA | 1106 | O95153 | |
| PHPLGAALPGPLPAS | 331 | Q16676 | |
| PLPAHSGALPFPSPG | 1026 | Q9H3S7 | |
| PGDPPPTLLHAGFLP | 516 | Q99742 | |
| AGFHVVPAAPPPGLP | 191 | O75808 | |
| PSAGVPRASPEPPGH | 916 | O75808 | |
| AGPPVPASHIAPAPV | 1616 | O14497 | |
| FPLHDGPFKTPPEGP | 291 | Q6IWH7 | |
| YLPPPDHGAPARGSP | 2181 | Q9Y618 | |
| VGAPAPSEPALPPGH | 361 | O60320 | |
| DPYAHPPGTPRPGIS | 2201 | Q8NEZ4 | |
| LGPPPPSFHLGGPAV | 356 | P43243 | |
| EPAPEPGHPAALYGP | 156 | Q99684 | |
| HADPGDDPGTPSPSP | 651 | Q9P107 | |
| RSHPGDPPSGLAPPL | 336 | P22083 | |
| SHPPPDPPILEGAVG | 851 | Q14C86 | |
| GAPAATPHLSLPPGP | 451 | O15054 | |
| TPPHPATPGDGFPSN | 1391 | Q96Q04 | |
| ALPHPPAGPFPEGAE | 91 | P52945 | |
| HFLPGPPGTAVPPPT | 36 | Q9NRQ2 | |
| PPPPPARDCGASGFH | 351 | Q6PJ61 | |
| SPHARPEVGIPDGPP | 36 | Q8IYA7 | |
| TPDFGEHLALLPPPP | 301 | Q9H1Q7 | |
| HPPIPFPCLGTPKGS | 81 | A2RU54 | |
| PSPPDVFAGFAPHPA | 141 | Q86XN8 | |
| HPTPGALEDPATPPA | 436 | Q8TDT2 | |
| ILAHPPGDSPSPEPS | 346 | P48742 | |
| HPAGPGESPFNAPHP | 106 | P10070 | |
| HSPAPSSEPPGGEDP | 1806 | Q9UMN6 | |
| QPDSGPPAAAPGHPL | 66 | P18627 | |
| AGHAPFPPPPAADGA | 136 | Q8N319 | |
| PVPGPPEAAHSLGPS | 606 | O75081 | |
| PAGVPGKPAAPHFLP | 181 | Q0VG06 | |
| GAPAASAHPLPPGPL | 76 | O95502 | |
| FTLPHQPAPPDAGPG | 771 | Q6NV74 | |
| EDPLPGPGSPSHSAP | 266 | Q9BQQ3 | |
| GLGLPEHFLPPPPSS | 951 | Q9Y3Q4 | |
| GAAAFLHEPPSPPPP | 466 | A8MVW0 | |
| AEPGPAPPPTAHPFA | 371 | A8MY62 | |
| PAVSLPPFPGFDPGT | 201 | Q8IXT2 | |
| PPFPGFDPGTSLQLP | 206 | Q8IXT2 | |
| PGLPPAGSPPDSHVL | 286 | P02765 | |
| PVPSPHPAPALGAAG | 231 | P49715 | |
| HSPGAPAPAGPEEEP | 66 | Q9UF56 | |
| ALGPEAPAPAKPGPH | 466 | Q9P0X4 | |
| LSESSVPGAPHGPPP | 201 | Q86UU0 | |
| EAPPSPEPPGALASH | 261 | O43281 | |
| AQTHPPGLPFPGPLS | 391 | Q96QS3 | |
| PGLPFPGPLSATHPL | 396 | Q96QS3 | |
| PLVSTPAGPFGAPPA | 846 | Q8TEH3 | |
| HVPAPFPGTPGPASP | 6 | Q63ZY3 | |
| PPPVDHSGVVPFPAP | 1296 | Q5VT52 | |
| PFPEGHPAVLPGEDP | 51 | Q86T03 | |
| GPPLPTPPVFTDHQE | 356 | Q5VVW2 | |
| FGPIGTSPPGPNPDH | 246 | Q92530 | |
| AAPPPGPPTASVFAG | 316 | O60548 | |
| GSPEGSPVLDPPPHL | 706 | Q9NXL9 | |
| PFTTPAPGPAHGPLL | 151 | Q8IVF1 | |
| PFTTPAPGPAHGPLL | 151 | A6NNL0 | |
| PFTTPAPGPAHGPLL | 151 | B1AL46 | |
| APATLARPPGHPAGP | 276 | O00268 | |
| PPATAAAGGPPHPQL | 646 | P17600 | |
| PHSPLPGALSSAPGP | 1056 | A8K8P3 | |
| GPPTGTVHPLSAPYP | 481 | Q9NRF2 | |
| VPTGAFDGPLHSPPP | 1191 | Q07890 | |
| VPAPGVPHSDVGEPP | 2496 | Q9UQ35 | |
| PPPQPPGVHSAGDSS | 811 | Q68EM7 | |
| GPSEPEHPATNPPGA | 11 | P98174 | |
| PPTAGPHPFASFHPG | 1356 | Q9P2R6 | |
| SPEVAAPEPPGSHPV | 581 | E7EW31 | |
| GFLSGSPPPPPALLH | 306 | Q7RTU9 | |
| SADPFAPVFVPPHPG | 2046 | Q9Y566 | |
| EAPATGPDLPHPGPD | 26 | Q7Z614 | |
| FGPQRSVHGPPPPLL | 6 | O15417 | |
| APPSPGVSGLFPPHE | 86 | Q8N2B8 | |
| PPDGSLDSPVPHLGP | 1536 | Q9C0A1 | |
| PHLGPPFLVPEPEAG | 1546 | Q9C0A1 | |
| PPPFLVDVDGNPHPS | 586 | Q8WWQ0 | |
| MSSPPLPTEGPFGHP | 996 | Q9UPX0 | |
| PVHSPGPAGPVSHPD | 331 | A6NJL1 | |
| PPGTPYELSLHGVPP | 1021 | P22105 | |
| FTPGNPPPHLPADVD | 211 | Q9NQB0 | |
| QHLKSSPPGFPFPGP | 1806 | Q92576 | |
| SDPGPHPEPGEGEPF | 796 | P19634 | |
| HGAAPFPAGPSGFPP | 1071 | Q86UU1 | |
| LPLPGFESPAGPAPS | 191 | Q15561 | |
| PFPHPLEPEPGVSAQ | 11 | O60343 | |
| GSPAEEPPAHAPSPG | 6 | Q06330 | |
| PGPLGPSAFFHPPTH | 626 | Q96JG9 | |
| PPGFSGLLPSPHPAC | 711 | Q86UK7 | |
| TFGGFPESPPPCPLH | 636 | A7E2V4 | |
| FGPEPGDHSDPLPPS | 166 | Q8N1G0 | |
| SPYLHPGATGDPPRP | 506 | Q9ULC8 | |
| PPGTPHSPSYAGPKA | 676 | Q9ULC8 | |
| GFLSGSPPPPPALLH | 306 | A6NGW2 | |
| QPPPAPCLGGVHPDF | 156 | A8MV65 | |
| HPAPSPGSCSPKFPG | 66 | P47974 | |
| DPGTTPPGHSVPVPA | 151 | Q96RJ3 | |
| PSLPVGPTAHGALPP | 211 | A5D8V6 | |
| GPTAHGALPPAPFPV | 216 | A5D8V6 | |
| PPPLAPAVDSLHAGP | 601 | Q9H0D2 |